Executive summary
Specialty medication fulfillment — particularly for high-demand therapies like GLP-1s — is exposing a fundamental flaw in how specialty pharma operations manage their warehouse workforce. Reactive hiring during demand spikes leads to compliance risk, fulfillment errors, burnout among experienced staff, and a cycle that costs far more than it saves. This white paper outlines the structural limitations of the surge-and-scramble model, what it actually costs operations, and how a business process outsourcing (BPO) approach builds the flexibility and continuity that specialty pharma fulfillment demands.
The pattern most warehouse leaders know too well.
Demand spikes. The floor is understaffed. What follows is a scramble to bring workers in and get them oriented — all while hoping the team holds together long enough to clear the backlog.
Sometimes, it works. Sometimes, errors increase and the pharma client starts asking questions.
The frustrating part is that this rarely reflects a failure of effort or planning. The team works hard during every surge. The operations leader does everything possible with what they have. The problem is that the workforce model itself was never designed to absorb sudden changes in volume, and no amount of hustle can fix a structural gap.
Why specialty medication fulfillment punishes reactive hiring.
In general warehousing, bringing in new workers during a volume spike is a manageable option. The learning curve is relatively short, and the cost of an occasional error is something most operations can absorb.
Specialty pharma fulfillment does not offer that margin. The products are high-cost and often temperature-sensitive, with strict handling protocols that vary by medication. Workers need to understand quality control procedures, compliance documentation, cold chain requirements, and client-specific standards — none of which can be covered in an afternoon orientation.
When you hire reactively during a surge, you’re putting undertrained people on the floor — making mislabeled shipments, cold chain breaks, documentation gaps, and picking errors more likely. In pharma, a fulfillment mistake is not just an inventory problem. It’s a patient who does not receive the medication they need, a compliance issue that triggers an audit, or a pharma client who begins evaluating whether your operation can truly handle the volume they’re sending.
The cost of those errors — rework, product waste, client penalties, and patient impact — often exceeds the cost of the vacancy the reactive hire was meant to fill. Speed without readiness creates more problems than it solves.
How much is the surge-and-scramble cycle costing you?
Every round of this cycle is more expensive than it appears on paper. When volume spikes, the immediate push is to get people on the floor as fast as possible. But recruiting takes time even under pressure — and once new workers arrive, supervisors must step away from their own responsibilities to train them.
In specialty pharma, that training is not optional or compressible. So for weeks, the operation runs with people who are not fully productive, while the people who are productive are stretched across two jobs.
During that ramp period, your most experienced workers carry the heaviest load. They absorb the extra volume and catch the mistakes that newer workers make. That works in the short term — but it takes a toll. Repeat the cycle, and you start losing the people your operation depends on most.
Then the surge passes, and you’re carrying headcount you will not need for months. When those workers leave, every bit of product and process knowledge leaves with them. The next surge starts from scratch.
The pattern persists because it’s familiar — but it’s quietly expensive on both ends.
What a scalable warehouse model actually looks like.
Building a scalable operation starts with defining the outcome rather than reacting to the problem. That means asking:
- What fulfillment accuracy does the warehouse need to maintain during peak volume?
- What shipping timelines are non-negotiable?
- What throughput targets do your pharma clients hold you to?
Those answers shape the workforce model.
A BPO partner that specializes in warehouse and distribution builds and manages a team around those targets — with flexible capacity designed into the model from the start. When volume increases, the operation expands with workers who are already prepared. Instead of spending weeks getting new people ready while supervisors do double duty, capacity arrives ready to contribute.
When volume normalizes, the BPO partner scales the team back. The surge-and-shed cycle that used to strain your budget and teams becomes something the model absorbs by design.
Day-to-day management sits with the BPO partner as well — which changes what operations leaders spend their time on. Instead of juggling scheduling and quality assurance across a constantly shifting workforce, they can focus on process improvements and client relationships.
Over time, this model builds something the surge-and-scramble cycle destroys: continuity. When turnover drops and workers stay longer, they develop real knowledge of products, client requirements, and process details that no orientation can fully teach. That accumulated expertise is what separates a warehouse that merely functions from one that gets more reliable with every quarter.
What your pharma clients see.
Specialty pharma operations depend on pharma client contracts — and those contracts get evaluated on performance during the moments that matter most: launches, demand spikes, and seasonal volume increases.
When fulfillment accuracy holds steady as volume increases and shipments go out on time (regardless of how fast demand grows), pharma clients see a partner they can trust with more volume and complexity. A distribution operation that scales without the errors and delays that typically accompany rapid growth is a more compelling partner at renewal time — and a harder one to replace.
The permanent team also feels the difference. Experienced warehouse workers who understand products and compliance standards are the hardest people to replace. A workforce model that stops burning them out is also what keeps them.
A workforce model built for the way demand works.
Specialty pharma volume does not arrive in neat, predictable increments. It surges with drug launches, shifts with formulary changes, and accelerates when a medication category like GLP-1s breaks into mainstream demand. A workforce model that only works during steady-state operations is not built for this industry.
The best response to a demand spike is a team that was ready before it started.
